SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-304514
Filing Date
2011-11-09
Accepted
2011-11-09 16:05:09
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d236742d10q.htm 10-Q 614390
2 FORM OF AMENDMENT TO CHANGE IN CONTROL AGREEMENTS d236742dex101.htm EX-10.1 9628
3 RULE 13A-14(A) CERTIFICATION OF CHIEF EXECUTIVE OFFICER d236742dex311.htm EX-31.1 7585
4 RULE 13A-14(A) CERTIFICATION OF CHIEF FINANCIAL OFFICER d236742dex312.htm EX-31.2 7810
5 SECTION 1350 CERTIFICATION OF CHIEF EXECUTIVE OFFICER d236742dex321.htm EX-32.1 3822
6 SECTION 1350 CERTIFICATION OF CHIEF FINANCIAL OFFICER d236742dex322.htm EX-32.2 3869
  Complete submission text file 0001193125-11-304514.txt   2293467

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT scln-20110930.xml EX-101.INS 319772
8 XBRL TAXONOMY EXTENSION SCHEMA scln-20110930.xsd EX-101.SCH 15441
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scln-20110930_cal.xml EX-101.CAL 35929
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE scln-20110930_lab.xml EX-101.LAB 123026
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scln-20110930_pre.xml EX-101.PRE 75413
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19825 | Film No.: 111191729
SIC: 2834 Pharmaceutical Preparations